Senior Director, National Accounts

About the Company

Definium Therapeutics is a late-stage clinical biopharmaceutical company on a mission to forge a new era of psychiatry by applying scientific rigor to psychedelics. Headquartered in New York and traded on Nasdaq, the company aims to develop accessible treatments for psychiatric and neurological disorders, including generalized anxiety, major depressive disorder, and PTSD.

Responsibilities

• Implement market access strategies and develop customer-specific access and reimbursement recommendations
• Own executive relationships with assigned PBMs, national commercial health plans, and key market access stakeholders
• Lead account planning, customer engagement, and business reviews for assigned accounts
• Engage payer pharmacy, medical, clinical, policy, and reimbursement stakeholders
• Partner cross-functionally to support payer access planning and reimbursement strategy
• Translate clinical, outcomes, and economic evidence into payer-relevant discussions
• Generate customer insights and market intelligence to support launch readiness
• Monitor payer trends, benefit design, formulary processes, and competitive activity

Requirements

• Bachelor's degree required; advanced degree preferred
• Minimum 10 years of market access, payer, reimbursement, or account management experience in biopharmaceuticals
• Demonstrated experience with national commercial health plans and PBMs
• Understanding of payer policy, reimbursement, benefit design, and formulary management
• Experience translating clinical and HEOR evidence into customer discussions
• Strong executive relationship management skills with payer stakeholders
• Willingness to travel 50% or more

Preferred Qualifications

• Experience in CNS, psychiatry, mental health, or behavioral health specialty product launches
• Experience engaging P&T committees or similar value assessment forums